What is it about?
A very short editorial suggesting how the whole company / academia / foundation /government drug discovery ecosystem could share molecules, models and data while at the same time retaining IP and selectively sharing others.
Why is it important?
Drug discovery is expensive, takes years and so any methods to try to speed it up or lower costs could be impactful. More collaboration and sharing could be an alternative and software can facilitate this.
The following have contributed to this page: Dr Sean Ekins